Filter posts

BIO Submits Comments on “Myriad” PTO Patent Guidance

On July 31st, BIO, alongside a group of international bioindustry trade associations submitted comments to …

NYT Columnist: Insurance Industry “Looking at the Costs of Sovaldi in the Wrong Way”

Margot Sanger-Katz’s article on a new drug that treats hepatitis C notes that despite the …

Greenwood Highlights Need for Bold Action to Address Alzheimer's

Last week, Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), participated and …

Puerto Rico: The New Hub for Ag-Biotech Innovation

 “Biotechnology Innovation—the union of scientific discovery and capital can flourish in a supportive research and …

1 of the 2,000 Articles Supporting GMO Safety

On Thursday July 24, 2014, The Huffington Post published a blog titled Genetically-Modified Organisms (GMOs) …

Treating Hepatitis C: Too Costly Not to Act

Today, The Hill published an op-ed – Treating hepatitis C: Too costly not to act …